266 related articles for article (PubMed ID: 32627033)
21. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract][Full Text] [Related]
22. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
23. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
[TBL] [Abstract][Full Text] [Related]
24. Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.
Sirivatanauksorn V; Dumronggittigule W; Dulnee B; Srisawat C; Sirivatanauksorn Y; Pongpaibul A; Masaratana P; Somboonyosdech C; Sripinitchai S; Kositamongkol P; Mahawithitwong P; Tovikkai C; Sangserestid P; Limsrichamrern S
Surg Oncol; 2020 Mar; 32():57-62. PubMed ID: 31751820
[TBL] [Abstract][Full Text] [Related]
25. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
26. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.
Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J
Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655
[TBL] [Abstract][Full Text] [Related]
27. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
[TBL] [Abstract][Full Text] [Related]
28. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
[TBL] [Abstract][Full Text] [Related]
29. Forkhead box L1 is frequently downregulated in gallbladder cancer and inhibits cell growth through apoptosis induction by mitochondrial dysfunction.
Qin Y; Gong W; Zhang M; Wang J; Tang Z; Quan Z
PLoS One; 2014; 9(7):e102084. PubMed ID: 25010679
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
[TBL] [Abstract][Full Text] [Related]
32. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
Lv YP; Shi W; Liu HX; Kong XJ; Dai DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):518-522. PubMed ID: 28239818
[TBL] [Abstract][Full Text] [Related]
33. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?
Nigam J; Chandra A; Kazmi HR; Parmar D; Singh D; Gupta V; M N
Tumour Biol; 2014 Sep; 35(9):9241-6. PubMed ID: 24935470
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription.
Huang X; He M; Huang S; Lin R; Zhan M; Yang D; Shen H; Xu S; Cheng W; Yu J; Qiu Z; Wang J
Mol Cancer; 2019 Nov; 18(1):166. PubMed ID: 31752867
[TBL] [Abstract][Full Text] [Related]
35. Clinical implication of TMPRSS4 expression in human gallbladder cancer.
Wu XY; Zhang L; Zhang KM; Zhang MH; Ruan TY; Liu CY; Xu JY
Tumour Biol; 2014 Jun; 35(6):5481-6. PubMed ID: 24532432
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia Inducible Factor-1alpha (HIF-1A) plays different roles in Gallbladder Cancer and Normal Gallbladder Tissues.
Wu Y; Meng D; You Y; Sun R; Fu M; Yan Q; Zhang S; Fang Z; Bao J; Li Y
J Cancer; 2021; 12(3):827-839. PubMed ID: 33403040
[No Abstract] [Full Text] [Related]
37. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
38. Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer.
Yang G; Lu Z; Meng F; Wan Y; Zhang L; Xu Q; Wang Z
Sci Rep; 2022 Jun; 12(1):10072. PubMed ID: 35710767
[TBL] [Abstract][Full Text] [Related]
39. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
